Authors


Marc Toeteberg-Harms, MD, FEBO

Latest:

AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD

A systematic review and meta-analysis highlights the safety and efficacy of excimer laser trabeculostomy as an implant-free MIGS procedure for managing open-angle glaucoma and ocular hypertension, either alone or in combination with cataract surgery.


Clemens Strohmaier, PhD

Latest:

AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD

The Elios procedure increased aqueous humor outflow in all investigated eyes, but further studies are needed to correlate these improvements with its clinical efficacy.


Gordana Sunaric-Mégevand, MD

Latest:

MIGS helping to personalize glaucoma surgery options

Although minimally invasive procedure gives hope, additional research is required.


Meghana Chalasani

Latest:

Shine on social media like ModaMD: Real World Ophthalmology

An overview of Jesse Berry’s advice for starting and growing a social media account


Marguerite B. McDonald, MD, FACS

Latest:

From firsts to the future: A pioneer's perspective on ophthalmology

Marguerite B. McDonald, MD, FACS, shares a front-row view of ophthalmology’s “revolution with a capital R."


Marjan Farid, MD

Latest:

Boosting short-term dry eye management in patients

Fast-acting efficacious options are key to treating acute inflammation


Benjamin Lin, MD

Latest:

The future of ophthalmology training is here—and it’s digital

Virtual reality and artificial intelligence are reshaping medical education.




Giulia Corradetti, MD

Latest:

ARVO 2025: Post-hoc analysis on GATHER 2 clinical trial data

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.


Robert S. Feder, MD

Latest:

Q&A: Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD

Course director Robert S. Feder, MD, shares how the monthly Zoom sessions aim to deliver clinical pearls and foster cross-subspecialty learning.


Sahar Bedrood, MD, PhD

Latest:

Treating Angle Closure and Elevated IOP with Topical Therapy and Canaloplasty

An expert discusses how she managed an unusual case of a patient with high myopia with angle closure and elevated intraocular pressure (IOP) through cataract extraction with toric lens implantation, combined with canaloplasty and endocyclophotocoagulation (ECP) to address both the refractive needs and anatomical causes of the condition.


Justin Schweitzer, OD, FAAO

Latest:

IKA Keratoconus Symposium 2023: Strategies for early diagnosis

At the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.


Gregory Moloney, FRANZCO, FRCSC

Latest:

ASCRS 2025: Rotational stability and outcomes with 'monofocal plus' toric IOL with Gregory Moloney, FRANZCO, FRCSC

A study reports minimal rotation and improved near vision following implantation of the Eyhance toric lens.


Elise Kramer, OD, FAAO, FSLS

Latest:

Keratoconus and perfect vision: Is it possible?

Eye care providers must look beyond visual acuity in screening for disease.


Emily Rich

Latest:

Children’s mental health and the impact of vision impairment

Two studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.



David S. Boyer, MD

Latest:

Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.


Andrew S. Morgenstern, OD, FAAO, FNAP

Latest:

IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&A

President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.


SPONSORED BY IONIS PHARMACEUTICALS

Latest:

Connecting the dots between the complement pathway and geographic atrophy

Currently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)


Jordan Rosenfeld

Latest:

The tech savvy physician: How AI will transform your practice

Investigators find technology aids instruction of medical students


Nicole Bajic, MD

Latest:

Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD

In episode 1, Bill Trattler, MD, shares practical advice on documentation, patient communication, keratoconus management, and advanced lens technology.


Moon Jeong Lee, MD

Latest:

The impact of vision loss on aging: A glaucoma fellow’s perspective

Moon Jeong Lee, MD, shares how volunteering in geriatric care shaped her career path.


John C. Baldinger, MD

Latest:

Femtosecond laser-assisted cataract surgery: One physician’s story

Ophthalmologist outlines his journey with the procedure as a late adopter.


Elaine Ye Wang, MD

Latest:

BLOG: MicroPulse TLT for patients who struggle with drops

In cases where patients struggle with applying or tolerating eye drops, especially after previous selective laser trabeculoplasty (SLT) treatment, MicroPulse transscleral laser therapy (TLT) offers a practical solution.


Polat Goktas, PhD

Latest:

Ophthalmology balances the promises and challenges of AI

Sophisticated programs require an evolving mindset.


Jithin Yohannan, MD, MPH

Latest:

AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH

An AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma management, especially for nonspecialists.


Peter Hnik, MD, MHSc

Latest:

Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucoma

A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.


Akihiro Kakehashi, MD, PhD

Latest:

The truth about invisible posterior vitreous structures

The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.


Ashtyn Zapletal

Latest:

Pigskins and perception: How neuro-ophthalmology influences NFL referees

Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.

© 2025 MJH Life Sciences

All rights reserved.